BioScrip
IR Contacts | Financial Tear Sheet | E-mail Alerts
Corporate Profile

BioScrip, Inc. is a leading national provider of infusion and home care management solutions. BioScrip partners with physicians, hospital systems, skilled nursing facilities, healthcare payors, and pharmaceutical manufacturers to provide patients access to post-acute care services. BioScrip operates with a commitment to bring customer-focused pharmacy and related healthcare infusion therapy services into the home or alternate-site setting. By collaborating with the full spectrum of healthcare professionals and the patient, BioScrip provides cost-effective care that is driven by clinical excellence, customer service, and values that promote positive outcomes and an enhanced quality of life for those it serves. BioScrip provides its infusion and home care services from over 70 locations across 28 states.

BioScrip also offers complete Pharmacy Benefit Management programs that include customized benefit plan design, pharmacy network management and sophisticated reporting capabilities that deliver improved clinical and economic outcomes.

Stock Quote
BIOS (Common Stock)
ExchangeNASDAQ (US Dollar)
Price$2.89
Change (%)0.00 (0.00%)
Volume689,993
Data as of 09/30/16 4:15 p.m. ET
Refresh quote
Events
There are currently no webcasts scheduled at his time.
There are currently no events scheduled.
More Events >>
Press Releases
DateTitlePrint
09/09/16BioScrip Completes Acquisition of Home SolutionsPrinter Friendly Version
09/02/16BioScrip and Home Solutions Enter Into Amended Asset Purchase Agreement to Expedite ClosingPrinter Friendly Version
08/12/16BioScrip Enters into a Tax Asset Protection Plan to Protect its Valuable Tax AssetsPrinter Friendly Version
More Press Releases >>
SEC filings
Filing DateFormDescription
09/29/16PRE 14AA preliminary proxy statement providing notification matters to be brought to a vote
09/23/163Initial filing by director officer or owner of more than ten percent.
09/23/163Initial filing by director officer or owner of more than ten percent.
09/23/163Initial filing by director officer or owner of more than ten percent.
More SEC Filings >>
Proxy Materials
Title
Download Documentation Proxy Supplement
Download Documentation Proxy Statement
Download Documentation 2014 Annual Report on Form 10-K
Get help downloading or viewing the above file types
BioScrip Corporate Offices

1600 Broadway, Suite 950
Denver, CO 80202
Phone: (720) 697-5200


Primary IR Contact
Lisa Wilson
In-Site Communications, Inc.
Phone: (212) 452-2793
E-mail: lwilson@insitecony.com

Transfer Agent
American Stock Transfer & Trust Co.
59 Maiden Lane
New York, NY 10038
Phone: (718) 921-8124

Accountants
KPMG LLP
4200 Wells Fargo Center
90 South Seventh Street
Minneapolis, MN 55402
Phone: (612) 305-5000

Data provided by Nasdaq. Minimum 15 minutes delayed.
^ Back to Top